Treatment of multifocal lymphoma of bone with intensified promace- cytabom chemotherapy and involved field radiotherapy

American Journal of Hematology

Volumn 58, Issue 1, 1998, Pages 1-7

  Rapoport, A P ^a,b   Constine, L S ^a   Packman, C H ^a   Rosier, R N ^a   O'Keefe, R ^a   Hicks, D G ^a   Rubin, S J ^a   Rowe, J M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bone; Chemotherapy; Dose escalation; Lymphoma; Radiotherapy

Indexed keywords

BLEOMYCIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; MALE; NONHODGKIN LYMPHOMA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; VINCRISTINE;

EID: 0031949410     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199805)58:1<1::AID-AJH1>3.0.CO;2-X     Document Type: Article

References (19)

1. Oberling C: Les reticulosarcomes et les reticuloendotheliosarcomes de la moelle osseuse (sarcomes d'Ewing). Bull Assoc Fr Etude Cancer (Paris) 17:259, 1928.
2. Parker F, Jackson H, Jr.: Primary reticulum cell sarcoma of bone. Surg Gynecol Obstet 68:45, 1939.
3. Freeman C, Berg JW, Cutler SJ: Occurrence and prognosis of extranodal lymphoma. Cancer 29:252, 1989.
4. Huvos AG: Primary non-Hodgkin's lymphoma of bone. In Huvos AG (ed): "Bone Tumors: Diagnosis, Treatment, and Prognosis," 2nd ed. Philadelphia: Saunders 1991.
5. Ostrowski ML, Unni KK, Banks PM, et al.: Malignant lymphoma of bone. Cancer 58:2646, 1986.
6. Kwak L, Halpern J, Olshen RA, Horning SJ: Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: Results of tree-structured survival analysis. J Clin Oncol 8:963, 1990.
7. DeVita VT, Hubbard SM, Longo DL: The chemotherapy of lymphomas. Looking back, moving forward: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 47:5810, 1987.
8. Fisher RI, Gaynor ER, Dahlberg S, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002, 1993.
9. Gordon LI, Andersen J, Habermann TM, et al: Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: Determination of the maximum-tolerated dose of ProMACE-CytaBOM. J Clin Oncol 14:1275, 1996.
10. Kaplan EL, Meier P: Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:457, 1958.
11. Shi Z-R, Itkowitz SH, Kim YS: A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem 36:317, 1988.
12. Shipp MA, Harrington DP for The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A Predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987, 1993.
13. Dosoretz DE, Raymond AK, Murphy GF: Primary lymphoma of bone. The relationship of morphologic diversity to clinical behavior. Cancer 50:1009, 1982.
14. Clayton F, Butler JJ, Ayala AG, et al: Non-Hodgkin's lymphoma in bone. Pathologic and radiologic features with clinical correlates. Cancer 60:2494, 1987.
15. Baar J, Burkes RL, Bell R, et al: Primary non-Hodgkin's lymphoma of bone. A clinicopathologic study. Cancer 73:1194, 1994.
16. Pettit CK, Zukerberg LR, Gray MH, et al: Primary lymphoma of bone. A B-cell neoplasm with a high frequency of multilobated cells. Am J Surg Pathol 14:329, 1990.
17. Fairbanks RK, Bonner JA, Inwards CY, et al: Treatment of stage IE primary lymphoma of bone. Intl J Radiat Oncol Biol Phys 28:363, 1994.
18. Chan JKC, Ng C-S, Hui P-K, et al: Anaplastic large cell Ki-1 lymphoma of bone. Cancer 68:2186, 1991.
19. Hicks DG, Gokan T, O'Keefe RJ, et al: Primary lymphoma of bone. Correlation of magnetic resonance imaging features with cytokine production by tumor cells. Cancer 75:873, 1995.